Early Passive Verticalization in Critically Ill Patients

NCT02270762 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2015-11-18

No results posted yet for this study

Summary

In the critically patient bed rest and inmovilization are some of the responsable of the development of respiratory complications. Early physical exercise is a tool to prevent respiratory complications as lost of respiratory muscle strength, decrease in functional residual capacity and hypoxemia improving oxygenation. In some cases critically ill conditions implies use of pharmacological sedation. That condition limit the active physical exercise. However, some technicals aids as Tilt table allows execution of passive early movilization.

The aim of this study is to assess the effect of early passive verticalization assisted by tilt table on alveolar recruitment and pulmonary ventilation in intensive care unit (ICU) patients, evaluated with electrical impedance tomography (EIT) ICU patients included at day of evaluation will be evaluated consecutively with EIT in three stages; 1) in the supine position (at 30° of inclination), 2) verticalized in tilt table (at 60º of inclination) 3) in the supine position (at 30° of inclination)

Conditions

  • Critical Illness

Interventions

OTHER

Rest in bed

OTHER

Passive verticalization

OTHER

Rest in bed

Sponsors & Collaborators

  • Cliniques universitaires Saint-Luc- Université Catholique de Louvain

    lead OTHER

Principal Investigators

  • Charlotte Meaux, PT · Cliniques universitaires Saint-Luc- Université Catholique de Louvain (StLuc)

  • Cheryl E Hickmann, PT, PhD student · Cliniques universitaires Saint-Luc- Université Catholique de Louvain (StLuc)

  • Jean Roeseler, PT, PhD · Cliniques universitaires Saint-Luc- Université Catholique de Louvain (StLuc)

  • Pierre-François Laterre, MD · Cliniques universitaires Saint-Luc- Université Catholique de Louvain (StLuc)

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02270762 on ClinicalTrials.gov